European Monitoring Centre for Drugs and Drug Addiction. (2011). Cost and financing of drug treatment services in Europe : an exploratory study. Selected issues. Luxembourg: Publications Office of the European Union.
Abstract: Recent estimates suggest that, each year, over 1 million Europeans receive treatment for problems related to the use of illicit drugs (EMCDDA, 2010). Of these, more than half receive opioid substitution treatment for problems related to opioid drugs, primarily heroin. The current levels of provision of drug treatment services in the European Union are the result of an expansion of services that has taken place during the last two decades. For much of that time, services expanded against a background of a growing drug problem, and one in which economic conditions were largely favourable. Now, however, in an era of cuts in government expenditure, managing the costs of treatment and ensuring the highest quality and best outcomes for the lowest possible cost are priorities. While measuring and improving drug treatment outcomes have been relatively high on the research agenda in recent years, the cost of treatment has received far less research attention. Addressing this information gap is likely to have a number of benefi ts for both decision-makers and treatment providers. On the one hand, service providers need accurate information on the costs of service provision in order to plan the allocation of resources. On the other, decision-makers and funders can use such information as a means of cost control, for example, by comparing costs of similar services or those of alternative providers of similar services. Finally, as a part of a fuller economic analysis, information on service costs is needed to determine the cost-effectiveness of interventions and treatment programmes. The cost of drug treatment in Europe is looked at from two main angles in this Selected issue. First, it presents an overview of the main sources of drug treatment funding and the financing mechanisms that are employed in European countries. The available data are presented on who is paying for drug treatment, how funding is organised, and how funding is distributed among different treatment modalities. This is followed by an analysis of the unit costs of different types of drug treatment. Costs related to opioid substitution treatment including the costs of substitution medication for a number of European countries are presented here. This publication keeps a tight focus on the cost of drug treatment and does not attempt to undertake a broader economic analysis of the healthcare and social costs relating to illicit drugs. This Selected issue represents a fi rst attempt to provide a European overview of drug treatment costs, and individual countries are brought into focus to illustrate specifi c aspects of the analysis. This subject is both topical and methodologically challenging. The varying availability of information as well as the complexity of funding arrangements mean that, at best, only very incomplete estimates can be made of the costs of (or expenditure on) drug treatment in Europe.
Keywords: Aod; AOD use, abuse, and dependence; addiction; heroin; treatment and maintenance; detoxification; inpatient care; outpatient care; methadone; heroin-assisted treatment; financial management; treatment cost; treatment method; financial statement; financing; study; Europe; report
|
European Monitoring Centre for Drugs and Drug Addiction. (2011). Drug policy profiles : Portugal. Drug policy profiles. Lisbon: Publications Office of the European Union.
Abstract: The EMCDDA Drug policy profiles aim to describe some of the main characteristics of national drug policies in Europe and beyond. The profiles do not attempt to assess these policies, but instead outline their development and main features. The objective is to help readers — from researchers to policymakers — gain a better understanding of the way in which countries control drugs and respond to drug-related security, social and health problems. This first profile describes the national drug policy of Portugal, a policy that has attracted significant attention recently in the media and in policy debates. It considers national strategies and action plans, the legal context within which they operate and the public funds spent, or committed, to resource them. It also describes the political bodies and mechanisms set up to coordinate the response to the multi-faceted problem and the systems of evaluation that may help to improve future policy.
Keywords: history; AOD public policy strategy; drug offense; law; drug legalization; evaluation; Portugal
|
European Monitoring Centre for Drugs and Drug Addiction. (2011). General report of activities 2010 : including “Annual report of the EMCDDA's authorising officer”. General report of activities. Luxembourg: Office for Official Publications of the European Communities.
Abstract: The General report of activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its annual work programme. The report is a useful information source for all those seeking comprehensive information on the Centre and its work.
Keywords: monitoring; administration and management; cost-effectiveness; cooperation; communication; quality control; assessment; policy recommendations; European Monitoring Centre for Drugs and Drug Addiction (body); international area; Europe; annual report
|
European Monitoring Centre for Drugs and Drug Addiction. (2011). Work programme 2011. Work programmes and strategies. Luxembourg: Publications Office of the European Union.
Abstract: The 2011 work programme takes forward activities begun in 2010 to implement the EMCDDA’s three-year strategy (2010–12). Key themes of this strategy are the consolidation of core data, investment in more complex and policy-relevant analysis, and the development of a small number of new areas of strategic importance. Progress was made in all these areas in 2010, and this document details the next steps to be taken.
Keywords: government and politics; monitoring; AOD use, abuse, and dependence; international area; Europe
|
European Monitoring Centre for Drugs and Drug Addiction, & European Commission. (2010). The European Union and the drug phenomenon : frequently asked questions. Brochures. Luxembourg: Office for Official Publications of the European Communities.
Abstract: Respect for fundamental rights, protection of public health, well-being, social cohesion and security are the objectives that guide the actions taken by the European Union in the field of illicit drugs. The EU drugs strategy 2005–12 provides the framework for enhanced coordination between action taken at national, EU and international level and commits the members of the EU to tackle illicit drugs by striking a balance between reducing supply and demand. This joint publication between the EMCDDA and the European Commission brings together some of the key frequently asked questions on the EU’s drugs policy and how it functions. Further details can be found via the websites and other links provided at the end of each answer. The brochure exists in English and French language versions.
Keywords: addiction; AOD use, abuse, and dependence; chemical addiction; public health; public policy on AOD; illicit drug; coordination of activities; law enforcement; Europe; international area
|
Observatoire européen des drogues et des toxicomanies, & Commission européenne (Eds.). (2010). L'Union européenne et le phénomène des drogues : questions fréquemment posées. Brochures. Luxembourg: Office des publications de l'Union européenne.
Abstract: Respect for fundamental rights, protection of public health, well-being, social cohesion and security are the objectives that guide the actions taken by the European Union in the field of illicit drugs. The EU drugs strategy 2005–12 provides the framework for enhanced coordination between action taken at national, EU and international level and commits the members of the EU to tackle illicit drugs by striking a balance between reducing supply and demand. This joint publication between the EMCDDA and the European Commission brings together some of the key frequently asked questions on the EU’s drugs policy and how it functions. Further details can be found via the websites and other links provided at the end of each answer. The brochure exists in English and French language versions.
Keywords: addiction; AOD use, abuse, and dependence; chemical addiction; public health; public policy on AOD; illicit drug; coordination of activities; law enforcement; Europe; international area
|
Osservatorio europeo delle droghe e delle tossicodipendenze. (2010). Relazione annuale 2010 : evoluzione del fenomeno della droga in Europa. Annual report. Lussemburgo: Ufficio delle pubblicazioni ufficiali delle Comunità europee.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policymakers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: government and politics; international area; AOD public policy strategy; public policy on illicit drugs; other drug laws; social cost of AOD; research; prevention; treatment and maintenance; harm reduction; stigma; social integration; law enforcement; health care delivery; prison; cannabis; amphetamines; MDMA; ecstasy; LSD; hallucinogens of abuse; AOD supply; prevalence; AOD use pattern; nightlife; cocaine; crack cocaine; AOD effects and consequences; intravenous injection; opioids in any form; communicable disease; AODR mortality; spice; internet; monitoring; Europe; annual report
|
Observatoire européen des drogues et des toxicomanies. (2010). Rapport annuel 2010 : état du phénomène de la drogue en Europe. Rapport annuel. Luxembourg: Office des publications officielles des Communautés européennes.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policymakers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: government and politics; international area; AOD public policy strategy; public policy on illicit drugs; other drug laws; social cost of AOD; research; prevention; treatment and maintenance; harm reduction; stigma; social integration; law enforcement; health care delivery; prison; cannabis; amphetamines; MDMA; ecstasy; LSD; hallucinogens of abuse; AOD supply; prevalence; AOD use pattern; nightlife; cocaine; crack cocaine; AOD effects and consequences; intravenous injection; opioids in any form; communicable disease; AODR mortality; spice; internet; monitoring; Europe; annual report
|
European Monitoring Centre for Drugs and Drug Addiction. (2010). Annual report 2010 : the state of the drugs problem in Europe. Annual report. Luxembourg: Office for Official Publications of the European Communities.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policymakers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: government and politics; international area; AOD public policy strategy; public policy on illicit drugs; other drug laws; social cost of AOD; research; prevention; treatment and maintenance; harm reduction; stigma; social integration; law enforcement; health care delivery; prison; cannabis; amphetamines; MDMA; ecstasy; LSD; hallucinogens of abuse; AOD supply; prevalence; AOD use pattern; nightlife; cocaine; crack cocaine; AOD effects and consequences; intravenous injection; opioids in any form; communicable disease; AODR mortality; spice; internet; monitoring; Europe; annual report
|
Europäische Beobachtungsstelle für Drogen und Drogensucht. (2010). Jahresbericht 2010 : Stand der Drogenproblematik in Europa. Jahresbericht. Luxemburg: Amt für amtliche Veröffentlichungen der Europäischen Gemeinschaften.
Abstract: The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policymakers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures.
Keywords: government and politics; international area; AOD public policy strategy; public policy on illicit drugs; other drug laws; social cost of AOD; research; prevention; treatment and maintenance; harm reduction; stigma; social integration; law enforcement; health care delivery; prison; cannabis; amphetamines; MDMA; ecstasy; LSD; hallucinogens of abuse; AOD supply; prevalence; AOD use pattern; nightlife; cocaine; crack cocaine; AOD effects and consequences; intravenous injection; opioids in any form; communicable disease; AODR mortality; spice; internet; monitoring; Europe; annual report
|